158 related articles for article (PubMed ID: 38325840)
1. Not only baseline but cumulative exposure of remnant cholesterol predicts the development of nonalcoholic fatty liver disease: a cohort study.
Liu L; Wang C; Hu Z; Deng S; Yang S; Zhu X; Deng Y; Wang Y
Environ Health Prev Med; 2024; 29():5. PubMed ID: 38325840
[TBL] [Abstract][Full Text] [Related]
2. Remnant cholesterol, stronger than triglycerides, is associated with incident non-alcoholic fatty liver disease.
Cheng Y; Zhang Q; Li H; Zhou G; Shi P; Zhang X; Guan L; Yan F; Xu C
Front Endocrinol (Lausanne); 2023; 14():1098078. PubMed ID: 37214248
[TBL] [Abstract][Full Text] [Related]
3. Remnant Cholesterol Independently Predicts the Development of Nonalcoholic Fatty Liver Disease.
Huang H; Xie J; Zeng Y; Liu Z; Miao M; Xu L; Xu C
J Clin Endocrinol Metab; 2023 Oct; 108(11):2907-2915. PubMed ID: 37186667
[TBL] [Abstract][Full Text] [Related]
4. Higher serum uric acid to HDL-cholesterol ratio is associated with onset of non-alcoholic fatty liver disease in a non-obese Chinese population with normal blood lipid levels.
Zhu W; Liang A; Shi P; Yuan S; Zhu Y; Fu J; Zheng T; Wen Z; Wu X
BMC Gastroenterol; 2022 Apr; 22(1):196. PubMed ID: 35448944
[TBL] [Abstract][Full Text] [Related]
5. Risk for the development of non-alcoholic fatty liver disease: A prospective study.
Wang J; Ma L; Chen S; Xu L; Miao M; Yu C; Li Y; Xu C
J Gastroenterol Hepatol; 2018 Aug; 33(8):1518-1523. PubMed ID: 29381226
[TBL] [Abstract][Full Text] [Related]
6. Cumulative exposure to AHA Life's Essential 8 is associated with nonalcoholic fatty liver disease: a large cohort study.
Yaqin W; Shuwen D; Ting Y; Xiaoling Z; Yuling D; Lei L; Changfa W
Nutr Metab (Lond); 2024 Jun; 21(1):38. PubMed ID: 38937762
[TBL] [Abstract][Full Text] [Related]
7. LDL/HDL cholesterol ratio is associated with new-onset NAFLD in Chinese non-obese people with normal lipids: a 5-year longitudinal cohort study.
Zou Y; Zhong L; Hu C; Zhong M; Peng N; Sheng G
Lipids Health Dis; 2021 Mar; 20(1):28. PubMed ID: 33766067
[TBL] [Abstract][Full Text] [Related]
8. Association of remnant cholesterol with nonalcoholic fatty liver disease: a general population-based study.
Zou Y; Lan J; Zhong Y; Yang S; Zhang H; Xie G
Lipids Health Dis; 2021 Oct; 20(1):139. PubMed ID: 34657611
[TBL] [Abstract][Full Text] [Related]
9. Body Fat Distribution and Risk of Incident and Regressed Nonalcoholic Fatty Liver Disease.
Kim D; Chung GE; Kwak MS; Seo HB; Kang JH; Kim W; Kim YJ; Yoon JH; Lee HS; Kim CY
Clin Gastroenterol Hepatol; 2016 Jan; 14(1):132-8.e4. PubMed ID: 26226099
[TBL] [Abstract][Full Text] [Related]
10. Relationship Between Relative Skeletal Muscle Mass and Nonalcoholic Fatty Liver Disease: A 7-Year Longitudinal Study.
Kim G; Lee SE; Lee YB; Jun JE; Ahn J; Bae JC; Jin SM; Hur KY; Jee JH; Lee MK; Kim JH
Hepatology; 2018 Nov; 68(5):1755-1768. PubMed ID: 29679374
[TBL] [Abstract][Full Text] [Related]
11. Remnant Cholesterol Predicts Long-term Mortality of Patients With Metabolic Dysfunction-associated Fatty Liver Disease.
Huang H; Guo Y; Liu Z; Zeng Y; Chen Y; Xu C
J Clin Endocrinol Metab; 2022 Jul; 107(8):e3295-e3303. PubMed ID: 35521833
[TBL] [Abstract][Full Text] [Related]
12. Association between remnant lipoprotein cholesterol levels and risk of non-alcoholic fatty liver disease in non-obese populations: a Chinese longitudinal prospective cohort study.
Miao Y; Tao H
BMJ Open; 2023 May; 13(5):e069440. PubMed ID: 37147088
[TBL] [Abstract][Full Text] [Related]
13. Association between nonalcoholic fatty liver disease and incident diabetes mellitus among Japanese: a retrospective cohort study using propensity score matching.
Zheng X; Cao C; He Y; Wang X; Wu J; Hu H
Lipids Health Dis; 2021 Jun; 20(1):59. PubMed ID: 34130693
[TBL] [Abstract][Full Text] [Related]
14. Remnant cholesterol and severity of nonalcoholic fatty liver disease.
Huang H; Wang J; Wu L; Ruan J; Hou L; Shen C; Xu C
Diabetol Metab Syndr; 2023 Nov; 15(1):238. PubMed ID: 37986027
[TBL] [Abstract][Full Text] [Related]
15. NAFLD does not increase the risk of incident dementia: A prospective study and meta-analysis.
Huang H; Liu Z; Xie J; Xu C
J Psychiatr Res; 2023 May; 161():435-440. PubMed ID: 37043979
[TBL] [Abstract][Full Text] [Related]
16. Comparative Associations of Nonalcoholic Fatty Liver Disease and Metabolic Dysfunction-Associated Fatty Liver Disease With Coronary Artery Calcification: A Cross-Sectional and Longitudinal Cohort Study.
Sung KC; Yoo TK; Lee MY; Byrne CD; Zheng MH; Targher G
Arterioscler Thromb Vasc Biol; 2023 Mar; 43(3):482-491. PubMed ID: 36727522
[TBL] [Abstract][Full Text] [Related]
17. Nonalcoholic fatty liver disease (NAFLD) and associated mortality in individuals with type 2 diabetes, pre-diabetes, metabolically unhealthy, and metabolically healthy individuals in the United States.
Golabi P; Paik JM; Kumar A; Al Shabeeb R; Eberly KE; Cusi K; GunduRao N; Younossi ZM
Metabolism; 2023 Sep; 146():155642. PubMed ID: 37380016
[TBL] [Abstract][Full Text] [Related]
18. Risk of Cardiovascular Disease in Individuals With Nonobese Nonalcoholic Fatty Liver Disease.
Arvind A; Henson JB; Osganian SA; Nath C; Steinhagen LM; Memel ZN; Donovan A; Balogun O; Chung RT; Simon TG; Corey KE
Hepatol Commun; 2022 Feb; 6(2):309-319. PubMed ID: 34558862
[TBL] [Abstract][Full Text] [Related]
19. Association of non-high-density lipoprotein cholesterol trajectories with the development of non-alcoholic fatty liver disease: an epidemiological and genome-wide association study.
Lee JH; Kim J; Kim JO; Kwon YJ
J Transl Med; 2023 Jul; 21(1):435. PubMed ID: 37403158
[TBL] [Abstract][Full Text] [Related]
20. Circulating trimethylamine-N-oxide is associated with all-cause mortality in subjects with nonalcoholic fatty liver disease.
Flores-Guerrero JL; Post A; van Dijk PR; Connelly MA; Garcia E; Navis G; Bakker SJL; Dullaart RPF
Liver Int; 2021 Oct; 41(10):2371-2382. PubMed ID: 33993608
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
